[Use of an opiate analgetic buprenorphine in the craniofacial surgery and dentistry].
The authors characterize buprenorphine at various stages of total anesthesia and as an analgesic component of neuroleptanalgesia in combination with seduxen and droperidol. The agent was used during craniofacial and dental interventions. Buprenorphine provided stable neurovegetative protection of the patient during surgery and created analgesia with the minimal side effects which are characteristic of opioids.
Gripuk
S F
SF
Svirina
M A
MA
Borisova
A Iu
AIu
D002047:Buprenorphine / Q000008:administration & dosage*; D003813:Dentistry; D003975:Diazepam / Q000008:administration & dosage; D004329:Droperidol / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005145:Face / Q000601:surgery*; D006801:Humans; D009458:Neuroleptanalgesia; D012886:Skull / Q000601:surgery*; D013515:Surgery, Oral
D002047:Buprenorphine; D004329:Droperidol; D003975:Diazepam